ACAAI: Sanofi and Regeneron’s Dupixent pivotal study met all primary and secondary endpoints, reducing signs and symptoms of allergic fungal rhinosinusitis; sBLA accepted for FDA priority review Phase ...

Accountably's Offshore 2.0 delivers structured, review-ready work with SLAs, visibility, and control, helping CPA, EA, and ...

The AFL has received the final report from the independent review it commissioned into Associate Professor Paul McCrory and ...

A growing number of Australians are self-managing their superannuation. A new report suggests some may be getting advice that ...

Chancellor John Pollaers will be grilled about his leadership style at a Senate inquiry on Monday, following unrest at the ...

Shareholders, Investors, and followers are invited to join CEO Brett H. Pojunis on X Spaces for an open discussion on revenue ...